Malta - anglès - Malta Medicines Authority

actavis group ptc ehf - repaglinide - tablet - repaglinide 0.5 mg - drugs used in diabetes

Malta - anglès - Malta Medicines Authority

actavis group ptc ehf - repaglinide - tablet - repaglinide 1 mg - drugs used in diabetes

Malta - anglès - Malta Medicines Authority

actavis group ptc ehf - repaglinide - tablet - repaglinide 2 mg - drugs used in diabetes

Malta - anglès - Malta Medicines Authority

actavis group ptc ehf - repaglinide - tablet - repaglinide 4 mg - drugs used in diabetes

Malta - anglès - Malta Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - repaglinide - tablet - repaglinide 0.5 mg - drugs used in diabetes

Malta - anglès - Malta Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - repaglinide - tablet - repaglinide 1 mg - drugs used in diabetes

Malta - anglès - Malta Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - repaglinide - tablet - repaglinide 2 mg - drugs used in diabetes

Unió Europea - anglès - EMA (European Medicines Agency)

accord healthcare s.l.u. - repaglinide - diabetes mellitus, type 2 - drugs used in diabetes - repaglinide is indicated in patients with type-2 diabetes (non-insulin-dependent diabetes mellitus (niddm)) whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise.treatment should be initiated as an adjunct to diet and exercise to lower the blood glucose in relation to meals.

Canadà - anglès - Health Canada

novo nordisk canada inc - repaglinide - tablet - 0.5mg - repaglinide 0.5mg - meglitinides

Canadà - anglès - Health Canada

novo nordisk canada inc - repaglinide - tablet - 1.0mg - repaglinide 1.0mg - meglitinides